Back

GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Pharmacotherapy Antidiabetic Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mattia Galli

Sapienza University of Rome, Rome (Italy)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor D. Bhatt (New York City, US)
Presentation thumbnail
Doctor K. Dimitriadis (Athens, GR)
Abstract Video
Presentation thumbnail
Doctor P. Sun (Tianjin, CN)
Abstract Video
Presentation thumbnail
Doctor M. Rahman (Flushing, US)
Abstract Video

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Pharmacotherapy

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular prevention with GLP1 agonists in high or very-high cardiovascular risk irrespective of diabetes.
31 August 2024
thumbnail
Congress Presentation
Can GLP-1 receptor agonists improve crude outcomes associated with heart failure? A meta-analysis of randomized controlled trials comprising 78,806 patients
12 May 2024
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on atrial fibrillation incidence: a systematic review and meta-analysis
31 August 2025
thumbnail
Congress Presentation
The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources